Parkinson's disease (PD) is a neurodegenerative disorder that primarily affects dopamine-producing neurons in the substantia nigra. This article aims to provide a comprehensive understanding of the disease, its diagnosis, and management strategies.
The pathogenesis of PD is multifactorial, involving both genetic and environmental factors. The hallmark pathological feature is the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to striatal dopamine deficiency. This results in the classic motor symptoms of PD: bradykinesia, rigidity, and rest tremor.
Diagnosis of PD is primarily clinical, based on the presence of cardinal motor symptoms and the absence of atypical features or secondary causes. The Movement Disorder Society (MDS) clinical diagnostic criteria for PD is a widely accepted tool. Neuroimaging, although not routinely used, can aid in uncertain cases.
The management of PD is multidimensional, involving pharmacologic and non-pharmacologic interventions. Levodopa remains the most effective treatment for motor symptoms. Dopamine agonists, MAO-B inhibitors, and deep brain stimulation are other treatment options. Non-pharmacologic interventions include physical therapy and occupational therapy. Patient education and support are crucial components of care.
Understanding the pathophysiology, diagnosis, and management of Parkinson's disease is fundamental for healthcare professionals. While there is currently no cure, early diagnosis and comprehensive management can significantly improve the quality of life of patients. Continued research and advancements in therapy offer hope for future breakthroughs in the fight against this debilitating disease.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation